Welcome to our dedicated page for AMN HEALTHCARE SERVICES SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMN HEALTHCARE SERVICES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMN HEALTHCARE SERVICES's regulatory disclosures and financial reporting.
Fontenot Teri G. reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Teri G. Fontenot received a grant of 8,304 Restricted Stock Units as equity compensation. Each RSU represents a right to one share of AMN common stock. The RSUs vest on the earlier of one year from the May 1, 2026 grant date or the 2027 Annual Meeting of Shareholders, and settle upon the director's separation from service, based on her prior election.
AMN Healthcare Services director Jeffrey R. Harris acquired additional common shares through the vesting and settlement of Restricted Stock Units (RSUs). On May 1, 2026, RSU awards converted into a total of 43,063 shares of AMN common stock, with no open‑market purchases or sales reported.
The RSUs were granted under AMN equity plans, including awards from 2006–2010 and a 2025 grant. Several older RSU grants settled on May 1, 2026, which the footnotes identify as the date of the director's separation from service with the company. Following these settlements, Harris holds 67,262 shares of AMN common stock directly.
AMN Healthcare Services director Sylvia Trent-Adams reported routine equity compensation changes. On May 1, 2026, 8,325 shares of common stock were acquired upon vesting and exercise of previously granted Restricted Stock Units (RSUs) under the AMN Healthcare 2017 Equity Plan, bringing her direct common stock holdings to 16,797 shares after the transaction. The filing also shows a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one future share of common stock. These new RSUs vest on the earlier of the one-year anniversary of the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders.
Jones Daphne E reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Daphne E. Jones reported routine equity compensation activity. On May 1, 2026, 8,325 Restricted Stock Units (RSUs) vested and settled into 8,325 shares of AMN common stock, increasing her direct common stock holdings to 17,124 shares.
On the same date, she received a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan. Each RSU represents a right to receive one share of common stock and will vest on the earlier of the one-year anniversary of the grant or the company’s 2027 annual shareholder meeting, with settlement at her separation from service.
AMN Healthcare Services director Mark G. Foletta reported routine equity compensation activity. He acquired 8,325 shares of Common Stock through the vesting and exercise of Restricted Stock Units (RSUs), bringing his direct Common Stock holdings to 21,598 shares.
He also received a new grant of 8,304 RSUs, each representing a contingent right to one share of AMN Common Stock. According to the footnotes, these RSUs were granted on May 1, 2026 under the AMN Healthcare 2025 Equity Plan and vest on the earlier of one year after the grant date or the company’s 2027 Annual Meeting of Shareholders.
AMN Healthcare Services director Jorge A. Caballero reported compensation-related equity activity. On May 1, 2026, he exercised 8,325 Restricted Stock Units (RSUs), receiving the same number of AMN common shares, bringing his direct common stock holdings to 15,462 shares.
On the same date, he received a new award of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one share of common stock upon vesting. The filing shows no share sales; activity consists of an RSU vesting/exercise and a new RSU grant tied to board service.
Huber Celia P reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Celia P. Huber received a grant of 8,304 restricted stock units (RSUs) of AMN common stock as equity compensation. Each RSU represents one share of common stock and will vest on the earlier of one year from the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders, aligning her interests with long-term shareholder value.
AMN Healthcare Services, Inc. reported the results of its Annual Meeting of Shareholders held on May 1, 2026. Shareholders approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan, which had previously been approved by the Board subject to shareholder approval.
All nine director nominees received strong support, with individual "for" votes generally around 27–29 million and broker non-votes of 4,410,527 for each nominee. In total, shareholders voted on five proposals, with detailed for, against, abstain, and broker non-vote tallies disclosed and further descriptions of each proposal referenced in the company’s Definitive Proxy Statement filed on March 18, 2026.
AMN Healthcare Services Inc director Eric P. Palmer filed an initial Form 3 reporting his beneficial ownership in the company. The filing lists his holdings of Common Stock as zero, with 0 shares owned directly following the reported position.
AMN Healthcare Services Inc reported a Schedule 13G ownership filing by Vanguard Capital Management. Vanguard reported 1,960,648 shares beneficially owned as of 03/31/2026, representing 5.07% of the class. Vanguard: sole dispositive power over 1,960,648 shares and sole voting power for 283,222 shares.
The filing notes these holdings reflect securities managed across Vanguard Capital Management LLC and affiliated investment divisions and includes shares held by Vanguard funds and managed accounts. The report was signed on 04/29/2026.